Farnesoid X Receptor Modulates Renal Lipid Metabolism, Fibrosis, and Diabetic Nephropathy
Tao Jiang(Chongqing Medical University), Moshe Levi, Paul Wilson(University of Colorado Health), Mieko Iwahashi(University of Colorado Health), Xiaoxin X. Wang(Georgetown University), James A. Tallman(University of Colorado Health), Lois J. Arend, Jinping Li(China Animal Health and Epidemiology Center), Eileen Sutherland(University of Colorado Health), Pnina Scherzer(Hadassah Academic College), Hideaki Takahashi(University of Colorado Health)
Cited by 232
Related Papers
Triglycerides and Cardiovascular Disease
|Circulation|2011|1.9k
Restructuring of the Gut Microbiome by Intermittent Fasting Prevents Retinopathy and Prolongs Survival in <i>db/db</i> Mice
|Diabetes|2018|385
SGLT2 Protein Expression Is Increased in Human Diabetic Nephropathy
|Journal of Biological Chemistry|2017|302
FXR/TGR5 Dual Agonist Prevents Progression of Nephropathy in Diabetes and Obesity
|Journal of the American Society of Nephrology|2017|222
Bile Acid Receptor Activation Modulates Hepatic Monocyte Activity and Improves Nonalcoholic Fatty Liver Disease
|Journal of Biological Chemistry|2013|218